Overview Safety and Tolerability Study of Lu AF35700 After Repeated Dosing in Patients With Schizophrenia Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the tolerability and safety of Lu AF35700 after repeated oral dosing to patients with schizophrenia. Phase: Phase 1 Details Lead Sponsor: H. Lundbeck A/S